No Data
Regenxbio Closes Partnership With Nippon Shinyaku
REGENXBIO Announces Closing of Strategic Partnership With Nippon Shinyaku for MPS Diseases
Petroleum resources, light industry, etc. (additional) Rating
Upgraded - Bullish Code Stock Name Brokerage Firm Previous Changed After-------------------------------------------------------------<268A> Rigaku Nomura "Hold" "Buy" <3626> TIS GS "Hold" "Buy" <4528> Ono Pharmaceutical City "3" "2" <6752> Panasonic HD Morgan Stanley "Equal Weight" "Over Weight" <7735> Screen Morgan Stanley "Equal Weight" "Over Weight"
Mitsukoshi Isetan, Tsumura, ETC (additional) Rating
Upgraded - Bullish Code Stock Name Brokerage Firm Previous After ------------------------------------------------------------ <8697> JPX GS "Sell" "Hold" <9719> SCSK City "2" "1" Downgraded - Bearish Code Stock Name Brokerage Firm Previous After ------------------------------------------------------------
Rating information (Target Price change - Part 2) = Mitsukoshi Isetan, Japan New Drug ETC.
◎Mizuho Securities (three-stage: Buy > Hold > underperform) Mitsukoshi Isetan <3099.T> - "Hold" → "Hold", 2400 yen → 2600 yen Sotetsu Holdings <9003.T> - "Hold" → "Hold", 2900 yen → 2700 yen Mitsui Trust Holdings <9302.T> - "Hold" → "Hold", 4800 yen → 8000 yen ◎Morgan Stanley MUFG Securities (three-stage: Overweight > Equal Weight > Underweight) Nippon Shinyaku <4516.T> - "Eico"
Nippon Shinyaku: Summary of financial results for the 3rd quarter of the fiscal year ending 2025/3 [IFRS] (consolidated)